We are live on ! Find out more
HCA

Harbor Capital Advisors Portfolio holdings

AUM $1.47B
1-Year Est. Return 42.58%
This Fund
S&P 500
This Quarter Est. Return
+1.8%
1 Year Est. Return
+42.58%
3 Year Est. Return
+118.91%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$275M
AUM Growth
–
Cap. Flow
+$290M
Cap. Flow %
105.54%
Top 10 Hldgs %
32.71%
Holding
92
New
92
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
MSFT icon
Microsoft
MSFT
+$13M
2
TSLA icon
Tesla
TSLA
+$10.1M
3
LRCX icon
Lam Research
LRCX
+$9.32M
4
AMZN icon
Amazon
AMZN
+$9.22M
5
CRM icon
Salesforce
CRM
+$8.67M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 48.21%
2 Consumer Discretionary 18.52%
3 Healthcare 17.22%
4 Communication Services 9.83%
5 Financials 2.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
AVLR
76
DELISTED
Avalara, Inc.
AVLR
$897K 0.33%
+6,947
New +$1.08M
CCCC icon
77
C4 Therapeutics
CCCC
$427M
$895K 0.33%
+27,791
New +$1.1M
DTIL icon
78
Precision BioSciences
DTIL
$208M
$894K 0.33%
+4,027
New +$1.12M
FATE icon
79
Fate Therapeutics
FATE
$318M
$853K 0.31%
+14,577
New +$826K
ALGN icon
80
Align Technology
ALGN
$12.3B
$840K 0.31%
+1,278
New +$822K
ROKU icon
81
Roku
ROKU
$22.4B
$822K 0.3%
+3,600
New +$971K
DNTH icon
82
Dianthus Therapeutics
DNTH
$6.07B
$805K 0.29%
+11,358
New +$1.14M
NEE icon
83
NextEra Energy
NEE
$179B
$805K 0.29%
+8,619
New +$745K
AKUS
84
DELISTED
Akouos Inc
AKUS
$785K 0.29%
+92,374
New +$829K
QURE icon
85
uniQure
QURE
$3.12B
$665K 0.24%
+32,041
New +$919K
LOGC
86
DELISTED
LogicBio Therapeutics, Inc. Common Stock
LOGC
$653K 0.24%
+282,578
New +$956K
DOCU
87
DocuSign
DOCU
$11.3B
$567K 0.21%
+3,721
New +$848K
CABA icon
88
Cabaletta Bio
CABA
$455M
$541K 0.2%
+142,787
New +$1.52M
TCRR
89
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
$390K 0.14%
+83,619
New +$523K
ORTX
90
DELISTED
Orchard Therapeutics plc American Depositary Shares
ORTX
$364K 0.13%
+27,587
New +$456K
FRLN
91
DELISTED
Freeline Therapeutics Holdings plc American Depositary Shares
FRLN
$360K 0.13%
+12,168
New +$497K
PACB icon
92
Pacific Biosciences
PACB
$357M
$319K 0.12%
+15,596
New +$376K
1 2 3
4

Similar funds

KRSITF
Kentucky Retirement Systems Insurance Trust Fund Frankfort, Kentucky $1.47B AUM 27.58% 1-Year Est. Return
SRC
Shufro Rose & Co New York $1.47B AUM 19.38% 1-Year Est. Return
ACM
Adelante Capital Management Alameda, California $1.46B AUM 8.98% 1-Year Est. Return
LLL
Lynrock Lake LP Rye Brook, New York $1.46B AUM 17.55% 1-Year Est. Return
SWA
SFMG Wealth Advisors Plano, Texas $1.48B AUM 15.85% 1-Year Est. Return
L7C
Liberty 77 Capital Washington, District of Columbia $1.46B AUM 33.32% 1-Year Est. Return
HTI
Hikari Tsushin Inc Tokyo, Japan $1.45B AUM 3.37% 1-Year Est. Return
CHAM
Clear Harbor Asset Management Stamford, Connecticut $1.45B AUM 23.7% 1-Year Est. Return

Harbor Capital Advisors's Q4 2021 Portfolio in Review

Q4 2021 is the first quarter with a 13F filing on record for Harbor Capital Advisors, which disclosed 92 positions worth $275M. Its ten largest holdings account for 33% of the portfolio.

Its largest position is Microsoft: 39,952 shares worth $13.4M.

By sector, the portfolio is most concentrated in Technology at 48% of assets, followed by Consumer Discretionary and Healthcare.

  • Harbor Capital Advisors's largest Q4 2021 buy was Microsoft: 39,952 shares worth $13.4M.
  • Harbor Capital Advisors's ten largest holdings make up 33% of its $275M portfolio in Q4 2021.
  • Harbor Capital Advisors disclosed 92 positions in Q4 2021, its first 13F filing on record.

Based on Harbor Capital Advisors's 13F filing for Q4 2021, filed 4 Feb 2022.